FORM 3
        
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response...
0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      
1. Name and Address of Reporting Person * Traistaru Elena 2. Date of Event Requiring Statement (MM/DD/YYYY)
5/15/2020 

3. Issuer Name and Ticker or Trading Symbol Emerald Bioscience, Inc. [EMBI]
(Last)       (First)       (Middle)
EMERALD BIOSCIENCE INC., 130 NORTH MARINA DRIVE
4. Relationship of Reporting Person(s) to Issuer (Check all applicable)_____ Director                          _____ 10% Owner
___X___ Officer (give title below)        _____ Other (specify below)
Interim CFO and Secretary /
(Street)
LONG BEACH, CA 90803      
(City)             (State)             (Zip)
5. If Amendment, Date Original Filed(MM/DD/YYYY)
 

6. Individual or Joint/Group Filing(Check Applicable Line)_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4)
2. Amount of Securities Beneficially Owned
(Instr. 4)
3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)
4. Nature of Indirect Beneficial Ownership
(Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 4)
2. Date Exercisable and Expiration Date
(MM/DD/YYYY)
3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)
4. Conversion or Exercise Price of Derivative Security 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)
6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares

Explanation of Responses:
No securities are beneficially owned.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
Traistaru Elena
EMERALD BIOSCIENCE INC.
130 NORTH MARINA DRIVE
LONG BEACH, CA 90803


Interim CFO and Secretary

Signatures
/s/ Elena Traistaru 5/15/2020
**Signature of Reporting Person Date
Emerald Bioscience (QB) (USOTC:EMBI)
Historical Stock Chart
From Oct 2020 to Nov 2020 Click Here for more Emerald Bioscience (QB) Charts.
Emerald Bioscience (QB) (USOTC:EMBI)
Historical Stock Chart
From Nov 2019 to Nov 2020 Click Here for more Emerald Bioscience (QB) Charts.